Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.

Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the completion of a Type B Pre-IND meeting with the Division ...

Learn how caffeine affects brain chemicals and health, sleep, and mood. Understand safe daily limits, hidden sources, and signs you’re getting too much.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of ...

Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, ...

The Cleveland Clinic states that the “concern about creatine and hair loss stems from creatine’s effect on the hormone ...

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Explore the benefits of the Precision GLP-1 agonist, a new therapy that improves glycaemic control and reduces side effects.

A biased GLP-1 receptor agonist maintained glycemic control while reducing side effects in preclinical models. By selectively activating cAMP, this biased agonist approach may support safer diabetes ...

Creatine supplements boost muscle energy, and clinical evidence shows no direct link between creatine use, dihydrotestosterone levels, or hair loss.

Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) in a phase 2a clinical study, meeting the trial’s p ...